Heterogeneity in the tumor microenvironment (TME) of follicular lymphomas (FLs) can affect
clinical outcomes. Current immunotherapeutic strategies, including antibody-and cell-based …

Glucose catabolism, one of the essential pathways sustaining cellular bioenergetics, has
been widely studied in the context of tumors. Nevertheless, the function of various branches …

In vitro cell cultures are fundamental and necessary tools in cancer research and
personalized drug discovery. Currently, most cells are cultured using two-dimensional (2D) …

The efficacy of anti-cancer therapies depends on the genomic composition of the tumor, its
microenvironment, spatial organization, and intra-tumor heterogeneity. B-cell lymphomas …

The interaction between stromal and tumor cells in tumor microenvironment is a crucial
factor in Mantle cell lymphoma (MCL) progression and therapy resistance. We have …

Follicular lymphoma (FL), the most common indolent non-Hodgkin lymphoma, constitutes a
paradigm of immune tumor microenvironment (TME) contribution to disease onset …

In Mantle Cell Lymphoma (MCL), the role of macrophages within the tumour
microenvironment (TME) has recently gained attention due to their impact on prognosis and …

Intravascular large B‐cell lymphoma (IVLBCL) is a rare type of extranodal large B‐cell
lymphoma that is characterized by the proliferation of lymphoma cells in the lumina of small …

Research on the mechanism and application of checkpoint inhibitory receptors in
hematologic diseases has progressed rapidly. However, in the treatment of relapserefractory …

The immune system is one of the common targets of drugs' toxicity (Immunotoxicity) and/or
efficacy (Immunotherapy). Immunotoxicity leads to adverse effects on human health, which …